Disc Medicine, Inc. (GMTX)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Disc Medicine, Inc. (GMTX)
Company Performance

Current Price

as of Oct 16, 2024

$47.99

P/E Ratio

N/A

Market Cap

$1.43B

Description

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. The company was founded in October 2017 and is headquartered in Watertown, MA.

Metrics

Overview

  • HQWatertown, MA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerGMTX
  • Price$47.99+0.73%

Trading Information

  • Market Cap$1.43B
  • Float52.22%
  • Average Daily Volume (1m)267,325
  • Average Daily Volume (3m)213,399
  • EPS-$3.66

Company

  • RevenueN/A
  • Rev Growth (1yr)N/A
  • Net Income-$26.35M
  • Gross MarginN/A
  • EBITDA MarginN/A
  • EBITDA-$30.74M
  • EV$656.89M
  • EV/RevenueN/A
  • P/EN/A
  • P/SN/A
  • P/B2.92
Documents
SEC Filings
8-K (2024-08-08)
8-K (2024-06-14)
8-K (2024-05-09)
8-K (2024-04-02)
8-K (2024-03-21)
8-K (2024-02-26)
8-K (2024-02-07)
8-K (2023-12-12)
8-K (2023-12-11)
8-K (2023-12-05)
8-K (2023-11-09)
8-K (2023-11-02)
8-K (2023-10-23)
8-K (2023-10-10)
8-K (2023-09-29)
8-K (2023-08-11)
8-K (2023-06-16)
8-K (2023-06-12)
8-K (2023-06-09)
8-K (2023-05-15)
8-K (2023-04-19)
8-K (2023-03-31)
8-K (2023-02-14)
8-K (2023-01-25)
8-K (2023-01-23)
10-Q (2024-08-08)
10-Q (2024-05-09)
10-Q (2023-11-09)
10-Q (2023-08-11)
10-Q (2023-05-15)
10-K (2024-03-21)
10-K (2023-03-31)
Factset Street Account
Morgan Stanley upgrades ACAD, FOLD, IVVD, and RYTM; downgrades IRON, PRLD, PTCT, and VIGL (2023-12-19T12:27:49Z)
Disc Medicine reports Q3 EPS ($0.58) vs FactSet ($0.80) [9 est, ($1.18)-(0.67)] ($47.75, 0.00) (2023-11-09T13:31:58Z)
Disc Medicine initiates a Phase 1 study of DISC-3405 (anti-TMPRSS6 mAb) in healthy volunteers ($45.65, 0.00) (2023-10-03T12:33:21Z)
Disc Medicine announces planned departure of CFO Joanne Bryce ($43.06, 0.00) (2023-10-23T13:15:47Z)
Disc Medicine announces multiple presentations at ASH Annual Meeting and program updates ($45.99, 0.00) (2023-11-02T13:19:35Z)
Disc Medicine announces grant of U.S. patent for methods of treating erythropoietic protoporphyrias with bitopertin ($51.61, 0.00) (2023-11-14T21:47:32Z)